Your browser doesn't support javascript.
loading
Control of Cardiovascular Risk Factors in Patients with Chronic Obstructive Pulmonary Disease.
Hawkins, Nathaniel M; Peterson, Sandra; Ezzat, Allison M; Vijh, Rohit; Virani, Sean A; Gibb, Andrew; Mancini, G B John; Wong, Sabrina T.
Afiliação
  • Hawkins NM; Division of Cardiology.
  • Peterson S; Centre for Health Services and Policy Research.
  • Ezzat AM; La Trobe University, Melbourne, Victoria, Australia.
  • Vijh R; School of Population and Public Health, and.
  • Virani SA; Division of Cardiology.
  • Gibb A; Centre for Health Services and Policy Research.
  • Mancini GBJ; Division of Cardiology.
  • Wong ST; Centre for Health Services and Policy Research.
Ann Am Thorac Soc ; 19(7): 1102-1111, 2022 07.
Article em En | MEDLINE | ID: mdl-35007497
ABSTRACT
Rationale Cardiovascular disease accounts for one-third of deaths in patients with chronic obstructive pulmonary disease (COPD). Better control of cardiovascular risk factors in primary care could improve outcomes.

Objectives:

To define the prevalence, monitoring, treatment, and control of risk factors in patients with COPD.

Methods:

Repeated cross-sectional analysis of primary care electronic medical records for all patients with COPD in the Canadian Primary Care Sentinel Surveillance Network from 2013 to 2018 (n = 32,695 in 2018). A control group was matched 11 for age, sex, and rural residence (n = 32,638 in 2018). Five risk factors were defined using validated definitions including laboratory

results:

hypertension, dyslipidemia, diabetes, obesity, and smoking.

Results:

All risk factors were more common in patients with COPD compared with matched control subjects, including hypertension (52.3% vs. 44.9%), dyslipidemia (62.0% vs. 57.8%), diabetes (25.0% vs. 20.2%), obesity (40.8% vs. 36.8%), and smoking (40.9% vs. 11.4%), respectively. The mean Framingham risk score was 20.6% versus 18.6%, with 53.8% of patients with COPD being high risk (⩾20%). Monitoring of risk factors within the last year in patients with COPD in 2018 was suboptimal 71.8% hypertension, 39.4% dyslipidemia, 74.5% diabetes, 52.3% obesity. Smoking status was infrequently recorded in the electronic record. In those monitored, guideline recommended targets were achieved in 60.8%, 46.6%, 57.4%, 10.6% and 12.0% for each risk factor. Cardiovascular therapies including angiotensin-converting enzyme inhibitors (69%), statins (69%), and smoking cessation therapies (27%) were underused.

Conclusions:

In patients with COPD, major cardiovascular risk factors are common, yet inadequately monitored, undertreated, and poorly controlled. Strategies are needed to improve comprehensive risk factor management proven to reduce cardiovascular morbidity and mortality.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doença Pulmonar Obstrutiva Crônica / Dislipidemias / Hipertensão Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Ann Am Thorac Soc Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doença Pulmonar Obstrutiva Crônica / Dislipidemias / Hipertensão Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Ann Am Thorac Soc Ano de publicação: 2022 Tipo de documento: Article